The contention pushed by bripoz trends towards saying that
those that are happy with 1.75 have more compassion for cancer
victims. The rest of us are hindering their recovery by holding
out for more money!
Contrarily, logic suggests that the low price / low return on this
high risk area does not encourage investment in anti cancer
drugs – and therefore slows progress in solving the problem.
Anyway I’m optimistic a better offer will come. The low side
effects aspect of our drug is a key advantage.
GLTO
Cheers
VLA Price at posting:
$1.70 Sentiment: Hold Disclosure: Held
